Earnings summaries and quarterly performance for LAM RESEARCH.
Executive leadership at LAM RESEARCH.
Timothy M. Archer
President, Chief Executive Officer
Ava A. Harter
Senior Vice President, Chief Legal Officer and Secretary
Douglas R. Bettinger
Executive Vice President, Chief Financial Officer
Patrick J. Lord
Executive Vice President, Chief Operating Officer
Seshasayee (Sesha) Varadarajan
Senior Vice President, Global Products Group
Board of directors at LAM RESEARCH.
Abhijit Y. Talwalkar
Chair of the Board
Bethany J. Mayer
Director
Eric K. Brandt
Director
Ho Kyu Kang
Director
Ita M. Brennan
Director
John M. Dineen
Director
Jyoti K. Mehra
Director
Mark Fields
Director
Michael R. Cannon
Director
Sohail U. Ahmed
Director
Research analysts who have asked questions during LAM RESEARCH earnings calls.
Blayne Curtis
Jefferies Financial Group
6 questions for LRCX
Harlan Sur
JPMorgan Chase & Co.
6 questions for LRCX
Stacy Rasgon
Bernstein Research
6 questions for LRCX
Timothy Arcuri
UBS
6 questions for LRCX
Brian Chin
Stifel Financial Corp.
5 questions for LRCX
Vijay Rakesh
Mizuho
5 questions for LRCX
Atif Malik
Citigroup Inc.
4 questions for LRCX
CJ Muse
Cantor Fitzgerald
4 questions for LRCX
Krish Sankar
TD Cowen
4 questions for LRCX
Vivek Arya
Bank of America Corporation
4 questions for LRCX
Mehdi Hosseini
Susquehanna Financial Group
3 questions for LRCX
Thomas O’Malley
Barclays Capital
3 questions for LRCX
Timm Schulze-Melander
Rothschild & Co Redburn
3 questions for LRCX
Charles Shi
Needham & Company
2 questions for LRCX
Christopher Muse
Cantor Fitzgerald
2 questions for LRCX
Edward Yang
Oppenheimer & Co. Inc.
2 questions for LRCX
James Schneider
Goldman Sachs
2 questions for LRCX
Jim Schneider
Goldman Sachs
2 questions for LRCX
Joseph Moore
Morgan Stanley
2 questions for LRCX
Melissa Weathers
Deutsche Bank
2 questions for LRCX
Sreekrishnan Sankarnarayanan
Wolfe Research, LLC
2 questions for LRCX
Srinivas Pajjuri
Raymond James & Associates, Inc.
2 questions for LRCX
Toshiya Hari
Goldman Sachs Group, Inc.
2 questions for LRCX
Christopher Caso
Wolfe Research
1 question for LRCX
Joseph Quatrochi
Wells Fargo Securities, LLC
1 question for LRCX
Recent press releases and 8-K filings for LRCX.
- Fabric8Labs closed a $50 million funding round led by NEA and Intel Capital, with participation from Lam Capital (Lam Research’s corporate venture arm) and other investors.
- Proceeds will boost U.S. production capacity from 5 million to 22 million components per year, targeting thermal management, RF/wireless, and power electronics markets.
- The company’s patented Electrochemical Additive Manufacturing (ECAM) process delivers room-temperature, high-resolution 3D metal parts without extensive post-processing.
- Fabric8Labs’ U.S. facilities are ISO 9001 certified and ITAR registered, enabling seamless scale-up from prototyping to high-volume production.
- Lam delivered record revenues of $5.3 billion, gross margin of 50.6%, and operating margin of 35%, with revenue up 3% sequentially.
- Systems revenue mix: foundry 60%, memory 34% (non-volatile memory 18%, DRAM 16%), and logic & other 6%.
- Regional breakdown: China 43%, Taiwan 19%, and Korea 15% of total revenue.
- Q2 guidance: revenue of $5.2 billion ± $300 million, gross margin 48.5% ± 1%, operating margin 33% ± 1%, and EPS $1.15 ± $0.10.
- Capital returns: $990 million in share buybacks, $292 million in dividends, with $6.5 billion remaining authorization.
- Revenue of $5.32 billion, up 3% sequentially.
- U.S. GAAP gross margin of 50.4%, operating income margin of 34.4%, and diluted EPS of $1.24.
- Non-GAAP gross margin of 50.6%, operating income margin of 35.0%, and diluted EPS of $1.26.
- Cash, cash equivalents, and restricted cash of $6.7 billion; deferred revenue of $2.77 billion.
- Q2 guidance: revenue $5.20 billion ± $0.30 billion, GAAP gross margin 48.4% ± 1%, GAAP operating margin 32.9% ± 1%, and EPS $1.15 ± $0.10.
- Revenue of $5.32 billion, up 3% sequentially; U.S. GAAP gross margin 50.4% and operating margin 34.4%.
- U.S. GAAP diluted EPS of $1.24, down 8% Q/Q.
- Cash, cash equivalents, and restricted cash totaled $6.7 billion, up from $6.4 billion at the end of the June quarter.
- Q4 guidance: revenue of $5.20 billion ± $300 million; gross margin 48.4% ±1%; diluted EPS of $1.15 ± $0.10.
- Lam Research and JSR/Inpria have entered a non-exclusive cross-licensing and collaboration agreement to advance leading-edge semiconductor patterning, notably dry resist EUV lithography and next-generation materials.
- The partnership will integrate JSR/Inpria’s metal oxide photoresists with Lam’s etch, deposition, and Aether® dry resist technologies to support AI and high-performance computing chip production.
- Joint R&D will target metal oxide resists, low- and high-NA EUV patterning, advanced films, and new precursor materials for atomic layer etch/deposition, leveraging JSR’s acquisition of Yamanaka Hutech.
- Lam and Inpria have agreed to dismiss all claims in the Inpria v. Lam Research litigation and related IPR proceedings.
- Lam Research expects etch & deposition to grow from the low-30% toward the high-30% of total wafer fab equipment spend by 2028–2029, and plans to capture 50% of that incremental SAM with new tools Halo, Akara, and Vantex.
- Memory conversion spending is projected at roughly $40 billion over the next several years—with Lam holding about two-thirds share of etch & deposition upgrades—and advanced packaging exceeded $1 billion in revenue last year, contributing to a combined gate-all-around and packaging market north of $3 billion.
- For the September quarter, gross margins are guided at 50%, with December expected around 48% due to mix shifts and tariffs; Lam raised its quarterly dividend by 13% and will return at least 85% of free cash flow via dividends and ongoing accelerated share repurchases.
- China spending is seen strengthening in Q3 before a modest Q4 pullback, and Lam will apply for U.S. export licenses for international customers following Commerce’s waiver revocation.
- Lam Research’s Board approved a 13% increase in its quarterly dividend to $0.26 per share, up from $0.23.
- The dividend will be paid on October 15, 2025 to shareholders of record as of September 24, 2025.
- Future dividend payments remain subject to review and approval by the Board of Directors.
- Strong demand drivers were emphasized across key segments, including NAND upgrades, foundry, DRAM, and advanced 3D architectures driven by AI compute trends.
- Gross margin improvement was noted with margins rising from 46% to 49.5%, attributed to a successful close-to-customer strategy and operational enhancements.
- A significant $40B opportunity in NAND upgrades over the next several years was highlighted as a key long-term growth catalyst.
- The company's robust recurring revenue model, supported by the CSBG and strong free cash flow generation leading to consistent dividends and share buybacks, was also underlined.
- Transformation & Diversification: Lam Research has transitioned from a memory/NAND-centric model to a diversified portfolio focusing on leading-edge applications, including advanced etch, deposition, and packaging technologies.
- Robust Capital Intensity & WFE Growth: The company is benefiting from increased capital intensity, with strong growth in wafer fabrication equipment spending driven by the complexity of 3D devices and advanced packaging requirements.
- Geopolitical & Operational Adjustments: Despite export control restrictions impacting China sales and mid-year revenue forecasts, Lam is mitigating risks through a diversified global footprint, notably with an expanded facility in Malaysia boosting operating margins.
- Bylaws amended effective May 20, 2025, enabling stockholders with at least 20% ownership held continuously for one year to call special meetings, with updated disclosure and timing requirements.
- The document details stringent procedures and timelines for director nominations and proxy access, including the types of information required from both record stockholders and eligible stockholders.
Recent SEC filings and earnings call transcripts for LRCX.
No recent filings or transcripts found for LRCX.